Updates and Events
LRA-Funded Study Finds Lazy Enzyme that Triggers Autoimmunity

April 14, 2021 Dr. Boris Reizis and his team, working with a group of clinical rheumatologists led by Dr. Jill Buyon, have made a connection between an enzyme that prevents people’s immune systems from reacting to their own DNA and lupus activity. In a paper just published in the Journal of Experimental Medicine they report […] READ MORE

2021 Willie Colon Golf Outing

Monday, May 3, 2021 – The Willie Colon Golf Outing benefiting the Lupus Research Alliance Jean Davis Research Grant looks to once again raise thousands of dollars in crucial funds for lupus research programs — while increasing awareness of the disease. Held at the Canoe Brook Country Club in Summit, NJ, the Outing is the […] READ MORE

Celebrating National Siblings Day with Sisters Who Share Lupus

April 8, 2021 In honor of National Siblings Day, we’re bringing you the story of TwoBeingHealthy — two sisters and strong social media voices – Kate (30) and Em (33) – who are so close they seem almost like twins. They went to the same college, live together in Seattle, hang out with the same […] READ MORE

LRA Writes President Supporting Dr. Janet Woodcock for FDA Commissioner

March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments for lupus, the organization’s President and CEO, Mr. Kenneth M. Farber, submitted a letter to President Joseph Biden to express LRA’s strong support for Dr. Janet Woodcock to be nominated for Commissioner of the U.S. […] READ MORE

LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment

March 30, 2021 Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus erythematosus (SLE).  This study suggests that itolizumab, a monoclonal antibody selectively targeting the CD6-ALCAM pathway, was safe and well tolerated among people with SLE. [Source: Equillium, Inc. Press Release 3.30.21] The EQUALISE study is evaluating […] READ MORE

Lupus Research Alliance Announces 2020 Distinguished Innovator Awards Aimed at New Lupus Treatments

NEW YORK, March 25, 2021 — The Lupus Research Alliance proudly announces two exceptional recipients of the 2020 Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Jacques Banchereau, PhD and Ignacio Sanz, MD. Both projects funded by this grant are investigating different mechanisms altered in lupus patients that induce an autoimmune response. Their findings […] READ MORE

Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th!

      Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th! ·    Learn more about an upcoming study LRA is doing on COVID-19 vaccines in people with lupus ·    Network and talk to people who’ve been in a lupus trial ·    Speak with the researchers conducting lupus trials near you ·    Compete for prizes…and MUCH MORE […] READ MORE

Lupus Research Program – Driven by LRA Advocacy – Announces 10 New Grant Recipients

March 19, 2021 Ten new applications for promising scientific studies were just recommended for funding by the Lupus Research Program (LRP) within the Department of Defense! The dedicated Lupus Research Program was first established in 2017 under the Congressionally Directed Medical Research Programs operated by the Army Medical Research and Materiel Command in Ft. Detrick, […] READ MORE

Learn and connect with our community!